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The presence of many relevant biomarkers in interstitial fluid puts forward this bodily fluid as an analyte of 
interest for continuous monitoring of health indicators. Although research and industry have aimed many 
efforts in the direction of a continuous monitoring, to date there is not yet a system capable of that.  
One of the reasons that hampers the development towards continuity of the system is that most of the 
concepts are based in the analysis of blood, which sampling needs to be sparse and controlled in time.  
 
In recent reports, it has been shown that it is possible to extract interstitial fluid from the skin
1, 2
. Most 
interestingly, the fluid can be collected by minimally invasive methods, which is a preferred feature in a 
continuous analysis scenario, as it can help to avoid the risk of infection and discomfort in the patient. 
 
In this report we present the concept that we envisage for a continuous monitoring system in which 
interstitial fluid is sampled and analyzed on chip. By means of extracting the fluid from the skin with a 
painless insertion
3
 of hollow microneedles (shown in fig.1), it is possible to obtain a continuous sampling 
for in situ analysis of the concentration of present biomarkers. We are currently developing the integration 
of a microneedle array with an electrochemical/optical sensor to take care of the analysis of the collected 
biomarkers. 
  
Our final goal is to offer a system for continuous monitoring of the active metabolism of the individual.  
This would be helpful in the scenario of efficient treatment of various medical conditions, but also in the 
sport arena. The system could enable training programmes of elite athletes to be tailored to the subject 
during and after training. 
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Fig.1   Hollow silicon microneedle array, with 
heights of 300 µm and a bore hole of 
around 50 µm of diameter. 
Fig.2   Extraction of interstitial fluid from skin. 
The needles don’t reach the dermis, where 
nerve connections appear and would send 
pain signals to the brain 
microneedle 
 array 
